SIRT1 promotes doxorubicin‐induced breast cancer drug resistance and tumor angiogenesis via regulating GSH‐mediated redox homeostasis

Documenti analoghi

• HDAC inhibitor regulates the tumor immune microenvironment via pyroptosis in triple negative breast cancer
  di: Xue Yang, et al.
  Pubblicazione: (2024)
• LDHA‐mediated M2‐type macrophage polarization via tumor‐derived exosomal EPHA2 promotes renal cell carcinoma progression
  di: Xinxin Gan, et al.
  Pubblicazione: (2024)
• The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway
  di: Anna Han, et al.
  Pubblicazione: (2024)
• HER3 V104 mutations regulate cell signaling, growth, and drug sensitivity in cancer
  di: Rosalin Mishra, et al.
  Pubblicazione: (2024)
• Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway
  di: Junfeng Li, et al.
  Pubblicazione: (2024)